financetom
Business
financetom
/
Business
/
Why JD.Com Stock Is Up 27% Over The Past Week
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why JD.Com Stock Is Up 27% Over The Past Week
Oct 2, 2024 12:49 AM

JD.Com Inc ( JD ) shares are trading higher by 2.36% during Monday’s session and are higher by 27% over the past week. Shares of U.S.-listed Chinese companies are trading higher on continued strength amid stimulus efforts. September PMI data beat estimates but factory activity fell, which may raise stimulus hopes.

What Happened: JD.com ( JD ), one of China's largest e-commerce platforms, saw its stock soar by 27% over the past week, driven by several factors, including strong hopes for increased economic stimulus from the Chinese government and better-than-expected economic data.

Over the past week, JD.com's ( JD ) stock was propelled higher following the People’s Bank of China's aggressive monetary easing measures. The central bank cut the reserve requirement ratio (RRR) by 50 basis points, reducing it to 9.5%, which is set to inject around 1 trillion yuan ($140 billion) into the financial system.

Read Also: Fed Chair Jerome Powell Set To Speak As Economists Raise Concerns Over Risks Arising From Potential Policy Missteps And 2024 Election

This increased liquidity provides banks with more capital to lend, potentially easing financial pressures on businesses like JD.com ( JD ), which rely heavily on consumer spending and economic confidence to drive growth.

What Else: In addition to the RRR cut, the PBoC lowered key interest rates, including the seven-day repo rate and the 14-day reverse repo rate, marking the central bank's increasingly proactive stance toward stabilizing economic growth. The cuts come amid growing concerns about China’s economic slowdown, with the government clearly signaling its intent to bolster liquidity and stimulate demand.

Investors were further encouraged by the release of China's September PMI data. Although factory activity fell, signaling continued weakness in the industrial sector, the overall PMI beat expectations, fueling optimism that China's economy is not deteriorating as rapidly as feared.

The stronger-than-expected data, coupled with the prospect of further stimulus, sparked a rally in Chinese stocks across the board. JD.com ( JD ), which is often seen as a barometer for China’s domestic consumption, benefitted from this shift in sentiment, with investors betting that more stimulus measures could lead to increased consumer spending on e-commerce platforms.

Read Also: Fed Chair Jerome Powell Set To Speak As Economists Raise Concerns Over Risks Arising From Potential Policy Missteps And 2024 Election

Traders and investors can gain exposure to Baidu through KraneShares CSI China Internet ETF ( KWEB ) and iShares China Large-Cap ETF ( FXI ) .

How To Buy JD Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in JD.com’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, JD has a 52-week high of $42.68 and a 52-week low of $20.82.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kiniksa Pharmaceuticals Swings to Q2 Loss, Revenue Increases
Kiniksa Pharmaceuticals Swings to Q2 Loss, Revenue Increases
Jul 23, 2024
08:09 AM EDT, 07/23/2024 (MT Newswires) -- Kiniksa Pharmaceuticals ( KNSA ) reported Tuesday that it swung to a Q2 loss of $0.06 per share from earnings of $0.21 a year earlier. Three analysts polled by Capital IQ expected earnings of $0.01 per share. Revenue for the quarter ended June 30 was $108.6 million, compared with $71.5 million a year...
Quest Diagnostics raises 2024 profit, revenue forecasts on health tests demand
Quest Diagnostics raises 2024 profit, revenue forecasts on health tests demand
Jul 23, 2024
July 23 (Reuters) - Quest Diagnostics ( DGX ) raised its 2024 profit and revenue forecasts on Tuesday, banking on robust demand for its health tests. Demand for diagnostic tests has grown in recent quarters as more people, especially older adults, caught up on surgeries deferred during the pandemic. This performance is due to growth of new physician and hospital...
Philip Morris lifts annual profit forecast on nicotine pouch demand
Philip Morris lifts annual profit forecast on nicotine pouch demand
Jul 23, 2024
(Reuters) - Philip Morris International ( PM ) raised its annual adjusted profit forecast on Tuesday, owing to steady demand for its Zyn nicotine pouches and higher prices of its cigarettes. Its shares were up 2% in premarket trading after the company also beat expectations for second-quarter revenue. Zyn nicotine pouches have so far been at the forefront of the...
Moderna co-founder Robert Langer to step down from vaccine maker's board
Moderna co-founder Robert Langer to step down from vaccine maker's board
Jul 23, 2024
July 23 (Reuters) - Robert Langer, co-founder and a key figure behind Moderna's ( MRNA ) scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday. WHY IT MATTERS Langer played a crucial role in the development of Moderna's ( MRNA ) messenger RNA COVID vaccine, which is the biotech's only commercial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved